+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Automated and Closed Cell Therapy Processing Systems Market - Global Forecast 2025-2030- Product Image
Automated and Closed Cell Therapy Processing Systems Market - Global Forecast 2025-2030- Product Image
Sale

Automated and Closed Cell Therapy Processing Systems Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6081813
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Automated and closed cell therapy processing systems are reshaping advanced biomanufacturing by delivering operational rigor, improved reproducibility, and compliance for cell therapy workflows. As industry demands escalate, automation and integrated closed systems are increasingly recognized as pivotal to reducing process variability and meeting evolving regulatory expectations.

Market Snapshot: Automated and Closed Cell Therapy Processing Systems

The global landscape for automated and closed cell therapy processing systems continues to expand, driven by escalating stakeholder demand for consistent product quality and scalable biomanufacturing solutions. Innovations in microfluidics, digital process controls, and filtration technology are accelerating market adoption, as organizations move away from manual, variable processing and embrace solutions that safeguard against contamination and minimize operational risk. This shift is further supported by robust regional investments and collaborative efforts to streamline clinical translation.

Scope & Segmentation

This research report delivers a detailed analysis of the automated and closed cell therapy processing systems sector, providing insight across all major segmentation criteria and geographic markets.

  • Application Areas: Autoimmune diseases, cancer therapy, and regenerative medicine are prominent therapeutic segments.
  • Cell Source Types: Platforms include NK cells, stem cells, and engineered T cells, covering both pluripotent and multipotent lineages.
  • End User Categories: Biopharmaceutical companies, hospitals and clinics, and research institutes leverage these systems for commercial and clinical workflows.
  • Product Types: The portfolio includes consumables essential for cell separation and culture, precision instrumentation, and specialized software platforms.
  • Technology Platforms: Centrifugation, dead-end and tangential flow filtration, and microfluidics (channel-based and droplet-based) support critical process steps.
  • Regional Markets: Americas (including the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (notably the United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Featured Companies: Thermo Fisher Scientific Inc., Lonza Group Ltd., Miltenyi Biotec GmbH, Sartorius AG, Terumo BCT, Inc., Pall Corporation, Cytiva Life Sciences, Bio-Techne Corporation, Fujifilm Irvine Scientific, Inc., and MaxCyte, Inc.

Key Takeaways

  • Automation and closed processing are now strategic priorities, reducing manual intervention and minimizing error-prone, variable steps in manufacturing.
  • Leading providers differentiate by deploying modular design, sensor integration, and advanced software that enable continuous data capture and compliance with electronic record requirements.
  • The move to end-to-end automation streamlines workflows, enhances process consistency, and fosters rapid iteration and optimization of critical quality attributes.
  • Strategic alliances and partnerships, particularly between instrument manufacturers, software developers, and academic centers, support technology transfer, validation, and the agile development of new protocols.
  • Region-specific drivers—including reimbursement, regulatory environment, and infrastructure investment—necessitate tailored strategies for successful market entry and expansion.
  • Robust workforce upskilling and cross-functional governance are integral for maximizing automation investments and sustaining operational excellence.

Tariff Impact on the Cell Therapy Processing Market

The 2025 United States tariff measures have introduced cost uncertainties and procurement challenges for key reagents, consumables, and processing instrumentation. As a result, manufacturers have rebalanced supplier portfolios, increased investment in localized manufacturing, and initiated dual sourcing strategies to limit exposure. The tariff climate has also prompted a stronger focus on cross-jurisdictional partnerships, enhanced inventory management, and technology transfer frameworks, all essential for navigating extended lead times and customs complexities.

Research Methodology & Data Sources

This report employs a comprehensive research approach, combining structured interviews with industry stakeholders—including executives, process scientists, and supply chain professionals—with secondary analysis from regulatory documents, journals, and company white papers. Extensive data validation is achieved through cross-comparison of independent data streams covering process performance, compliance outcomes, and technology adoption trends.

Why This Report Matters

  • Enables executive decision makers to benchmark operational strategies and anticipate competitive shifts driven by advanced automation in cell therapy processing.
  • Delivers actionable insights into supply chain planning, compliance risk mitigation, and optimal investment paths for process technologies and partnerships.
  • Equips organizations with in-depth knowledge of emerging regulatory impacts and market segmentation for more precise market entry and expansion strategies.

Conclusion

Automated and closed cell therapy processing systems are setting new benchmarks for consistency, compliance, and innovation in biomanufacturing. This report equips decision makers with the insights needed to navigate complexities and succeed in an evolving landscape.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing integration of artificial intelligence for real-time monitoring and quality control in closed cell therapy processing systems
5.2. Adoption of modular single-use bioreactor modules to streamline scale-up of personalized cell therapy production
5.3. Advancements in closed-loop sensors for automated feedback control to maintain cell viability during processing
5.4. Regulatory alignment initiatives to standardize automated cell therapy workflows across global manufacturing sites
5.5. Integration of machine learning algorithms for predictive maintenance of closed cell processing equipment in GMP facilities
5.6. Emergence of closed single-use automated platforms for integrated cell washing and concentration steps to minimize contamination risk
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Automated And Closed Cell Therapy Processing Systems Market, by Primary Segmentations
8.1. Introduction
8.2. Application
8.2.1. Autoimmune Diseases
8.2.2. Cancer Therapy
8.2.3. Regenerative Medicine
8.3. Cell Source
8.3.1. Nk Cells
8.3.2. Stem Cells
8.3.3. T Cells
8.4. End User
8.4.1. Biopharmaceutical Companies
8.4.2. Hospitals & Clinics
8.4.3. Research Institutes
8.5. Product Type
8.5.1. Consumables
8.5.2. Instruments
8.5.3. Software
8.6. Technology
8.6.1. Centrifugation
8.6.2. Filtration
8.6.2.1. Dead End
8.6.2.2. Tangential Flow
8.6.3. Microfluidics
8.6.3.1. Channel Based
8.6.3.2. Droplet Based
9. Americas Automated And Closed Cell Therapy Processing Systems Market
9.1. Introduction
9.2. United States
9.3. Canada
9.4. Mexico
9.5. Brazil
9.6. Argentina
10. Europe, Middle East & Africa Automated And Closed Cell Therapy Processing Systems Market
10.1. Introduction
10.2. United Kingdom
10.3. Germany
10.4. France
10.5. Russia
10.6. Italy
10.7. Spain
10.8. United Arab Emirates
10.9. Saudi Arabia
10.10. South Africa
10.11. Denmark
10.12. Netherlands
10.13. Qatar
10.14. Finland
10.15. Sweden
10.16. Nigeria
10.17. Egypt
10.18. Turkey
10.19. Israel
10.20. Norway
10.21. Poland
10.22. Switzerland
11. Asia-Pacific Automated And Closed Cell Therapy Processing Systems Market
11.1. Introduction
11.2. China
11.3. India
11.4. Japan
11.5. Australia
11.6. South Korea
11.7. Indonesia
11.8. Thailand
11.9. Philippines
11.10. Malaysia
11.11. Singapore
11.12. Vietnam
11.13. Taiwan
12. Competitive Landscape
12.1. Market Share Analysis, 2024
12.2. FPNV Positioning Matrix, 2024
12.3. Competitive Analysis
12.3.1. Thermo Fisher Scientific Inc.
12.3.2. Lonza Group Ltd.
12.3.3. Miltenyi Biotec GmbH
12.3.4. Sartorius AG
12.3.5. Terumo BCT, Inc.
12.3.6. Pall Corporation
12.3.7. Cytiva Life Sciences
12.3.8. Bio-Techne Corporation
12.3.9. Fujifilm Irvine Scientific, Inc.
12.3.10. MaxCyte, Inc.
13. ResearchAI
14. ResearchStatistics
15. ResearchContacts
16. ResearchArticles
17. Appendix
List of Figures
FIGURE 1. AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 8. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 10. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. ASIA-PACIFIC AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. ASIA-PACIFIC AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 16. AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 17. AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET: RESEARCHAI
FIGURE 18. AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET: RESEARCHSTATISTICS
FIGURE 19. AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET: RESEARCHCONTACTS
FIGURE 20. AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CANCER THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CANCER THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY NK CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY NK CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STEM CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY T CELLS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY T CELLS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CENTRIFUGATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY DEAD END, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY DEAD END, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TANGENTIAL FLOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TANGENTIAL FLOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CHANNEL BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CHANNEL BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY DROPLET BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY DROPLET BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 109. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 110. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 111. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 112. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 113. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 114. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 115. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 118. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 119. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 122. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 123. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 124. CANADA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 125. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 126. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 127. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 130. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 131. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 138. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 139. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 140. MEXICO AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 207. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 208. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 209. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 212. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 213. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 214. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 215. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 216. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 217. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 220. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 221. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 222. GERMANY AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 223. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 224. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 225. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 228. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 229. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 236. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 237. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 238. FRANCE AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030 (USD MILLION)
TABLE 239. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2018-2024 (USD MILLION)
TABLE 240. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRIMARY SEGMENTATIONS, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY CELL SOURCE, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY FILTRATION, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA AUTOMATED AND CLOSED CELL THERAPY PROCESSING SYSTEMS MARKET SIZE, BY MICROFLUIDICS, 2025-2030

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Automated And Closed Cell Therapy Processing Systems market report include:
  • Thermo Fisher Scientific Inc.
  • Lonza Group Ltd.
  • Miltenyi Biotec GmbH
  • Sartorius AG
  • Terumo BCT, Inc.
  • Pall Corporation
  • Cytiva Life Sciences
  • Bio-Techne Corporation
  • Fujifilm Irvine Scientific, Inc.
  • MaxCyte, Inc.

Related Topics

Related Reports

Automated Cell Processing Systems for Cell Therapy Market - Global Forecast 2025-2030 - Product Image

Automated Cell Processing Systems for Cell Therapy Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation), By Type (Stem Cell Therapy), By Scale (Commercial Scale), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation), By Type (Stem Cell Therapy), By Scale (Commercial Scale), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 130 Pages
  • Global
From
Automated and Closed Cell Therapy Processing Systems - Global Strategic Business Report - Product Image

Automated and Closed Cell Therapy Processing Systems - Global Strategic Business Report

  • Report
  • 138 Pages
  • Global
From
Cell Processing Systems for Cell Therapy Market - Global Forecast 2025-2030 - Product Image

Cell Processing Systems for Cell Therapy Market - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Automated And Closed Cell Therapy Processing Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Automated And Closed Cell Therapy Processing Systems Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.